Pilot and Feasibility Study of Intra-articular Anti-CD14 for the Treatment of Knee Osteoarthritis

NCT07481474 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

FED

Sponsor class

Conditions

Knee Osteoarthritis (Knee OA)

Interventions

BIOLOGICAL: Atibuclimab (intra-articular)
OTHER: saline placebo

Sponsor

VA Office of Research and Development